NPRA

NPRA Banner

New Publication: MADRAC Bulletin December 2015

: Posted By User933; 04 March 2016; Hits: 14484

User Rating: 1 / 5

Click the image to download/view MADRAC Bulletin – Dec 2015.

Succinylated Gelatin Intravenous Infusion Products - Summary of Safety Review in 2015
Amlodipine: Possible Risk of Blurred Vision
Cardiovascular Adverse Events Related to Diclofenac
Direct Healthcare Professional Communications (DHPCs) Reviewed and Approved by NPCB in 2015
Montelukast: Risk of Thrombocytopenia
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: Risk of Severe Joint Pain
Fusafungine: Risk of Serious Allergic Reactions
New and Improved ADR Reporting Form (Blue Form)
ADR Reports Involving Anti-Tuberculosis Drugs

Click here for other issues of MADRAC Bulletin.

Rating:

( 1 Rating )

National Pharmaceutical Regulatory Agency (NPRA)

Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.

Phone: +603-7883 5400

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

NPRA Product Status